GlassScriptPhysician profile
Jon R Vanderweele
NPI 1598737801
$1,463.15
in general payments reported to CMS, 2019-2025
10 companies · $816 in 2025
The $816 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.58 · 2021: $111 · 2023: $132 · 2024: $331 · 2025: $816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711 · Travel and Lodging: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.21 |
| Travel and Lodging | $567.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $707.24 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Aerin Medical INC. | $194.55 | 2025 | |
| Glaxosmithkline, LLC. | $166.86 | 2021-2024 | Nucala |
| Genzyme Corporation | $151.64 | 2024-2025 | |
| Acclarent, INC | $58.43 | 2023 | Trudi Nav Cable |
| Stryker Corporation | $58.19 | 2023 | Minifess Sphenoid Seeker/Freer, Xpress Ent Dilation System, Cyclone Sinonasal Suction/Irrigation System |
| Regeneron Healthcare Solutions, INC. | $52.66 | 2024 | Dupixent |
| Intersect Ent, INC. | $43.53 | 2019 | |
| Smith+Nephew, INC. | $16.84 | 2019 | |
| Optinose US, INC. | $13.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Vanderweele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.